deltatrials
Completed PHASE2 INTERVENTIONAL 1-arm NCT01556243

Breast-Conserving Surgery and Radiation Therapy in Patients With Multiple Ipsilateral Breast Cancer

Impact of Breast Conservation Surgery on Surgical Outcomes and Cosmesis in Patients With Multiple Ipsilateral Breast Cancers (MIBC)

Sponsor: Alliance for Clinical Trials in Oncology

Conditions Breast Cancer
Interventions therapeutic conventional surgery whole breast irradiation
Updated 15 times since 2017 Last updated: Nov 7, 2023 Started: Jul 31, 2012 Primary completion: Jun 1, 2022 Completion: Apr 15, 2023
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01556243, this PHASE2 trial focuses on Breast Cancer and remains completed. Sponsored by Alliance for Clinical Trials in Oncology, it has been updated 15 times since 2012, reflecting substantial change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

~Jan 2017 – ~Mar 2017 · 59 days · monthly snapshot~Mar 2017 – ~May 2018 · 14 months · monthly snapshot~May 2018 – ~Jun 2018 · 31 days · monthly snapshot~Jun 2018 – ~Jun 2019 · 12 months · monthly snapshot~Jun 2019 – ~Aug 2020 · 14 months · monthly snapshot~Aug 2020 – ~Jan 2021 · 5 months · monthly snapshot~Jan 2021 – ~Sep 2021 · 8 months · monthly snapshot~Sep 2021 – ~May 2022 · 8 months · monthly snapshot~May 2022 – ~Jul 2022 · 2 months · monthly snapshot~Jul 2022 – ~May 2023 · 10 months · monthly snapshot~May 2023 – ~Dec 2023 · 7 months · monthly snapshot~Dec 2023 – ~Jul 2024 · 7 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshot~Sep 2025 – present · 10 months · monthly snapshot

Change History

15 versions recorded

  1. Sep 2025 — Present [monthly]

    Completed PHASE2

  2. Sep 2024 — Sep 2025 [monthly]

    Completed PHASE2

  3. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE2

  4. Dec 2023 — Jul 2024 [monthly]

    Completed PHASE2

  5. May 2023 — Dec 2023 [monthly]

    Completed PHASE2

    Status: Active Not Recruiting → Completed

▶ Show 10 earlier versions

  1. Jul 2022 — May 2023 [monthly]

    Active Not Recruiting PHASE2

  2. May 2022 — Jul 2022 [monthly]

    Active Not Recruiting PHASE2

  3. Sep 2021 — May 2022 [monthly]

    Active Not Recruiting PHASE2

  4. Jan 2021 — Sep 2021 [monthly]

    Active Not Recruiting PHASE2

  5. Aug 2020 — Jan 2021 [monthly]

    Active Not Recruiting PHASE2

  6. Jun 2019 — Aug 2020 [monthly]

    Active Not Recruiting PHASE2

  7. Jun 2018 — Jun 2019 [monthly]

    Active Not Recruiting PHASE2

  8. May 2018 — Jun 2018 [monthly]

    Active Not Recruiting PHASE2

  9. Mar 2017 — May 2018 [monthly]

    Active Not Recruiting PHASE2

  10. Jan 2017 — Mar 2017 [monthly]

    Active Not Recruiting PHASE2

    First recorded

Jul 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Alliance for Clinical Trials in Oncology
  • National Cancer Institute (NCI)
Data source: Alliance for Clinical Trials in Oncology

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Albuquerque, United States , Allentown, United States , Amarillo, United States , Ames, United States , Ann Arbor, United States , Asheboro, United States , Aurora, United States , Avon, United States , Baltimore, United States , Bangor, United States and 205 more locations